Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin

BACKGROUND: Gallbladder cancer (GBC) is likely to be diagnosed at progressive stages and shows a very poor prognosis. Combination therapy with gemcitabine and cisplatin (GEMCIS) has been widely used as first-line palliative chemotherapy for advanced GBC. This study was designed to investigate the ef...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Min su, Ryu, Ji Kon, Choi, Young Hoon, Choi, Jin Ho, Huh, Gunn, Paik, Woo Hyun, Lee, Sang Hyub, Kim, Yong-Tae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321682/
https://www.ncbi.nlm.nih.gov/pubmed/30611225
http://dx.doi.org/10.1186/s12885-018-5211-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321682/
https://www.ncbi.nlm.nih.gov/pubmed/30611225
http://dx.doi.org/10.1186/s12885-018-5211-y

Ejemplares similares